These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5759497)

  • 1. [A new therapeutic agent for essential hypertension].
    Devaleriola Y; Enderlé J
    Brux Med; 1968 Aug; 48(8):499-506. PubMed ID: 5759497
    [No Abstract]   [Full Text] [Related]  

  • 2. Debrisoquin sulfate: a clinical evaluation of a new antihypertensive agent.
    Blechman M; Sokol C; Moser M
    Curr Ther Res Clin Exp; 1969 Feb; 11(2):71-6. PubMed ID: 4975816
    [No Abstract]   [Full Text] [Related]  

  • 3. [New sympathoplegic antihypersensive agent: debrisoquin sulfate].
    Biron P
    Union Med Can; 1973 May; 102(5):1134-5. PubMed ID: 4712043
    [No Abstract]   [Full Text] [Related]  

  • 4. Debrisoquine sulphate--a new antihypertensive agent with minimal side-effects.
    Chen BT
    Singapore Med J; 1971 Apr; 12(2):106-9. PubMed ID: 4945291
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of Declinax in Nigerian hypertensives.
    Cole TO; Adadevoh BK
    Br J Clin Pract; 1970 Jun; 24(6):245-9. PubMed ID: 5456743
    [No Abstract]   [Full Text] [Related]  

  • 6. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
    Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
    Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effects of debrisoquine sulfate in hypertension].
    Liu HW; Chen CY
    Taiwan Yi Xue Hui Za Zhi; 1972 Mar; 71(3):189-95. PubMed ID: 4506851
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical study of the antihypertensive effect of tetrandrine.
    Chin Med J (Engl); 1979 Mar; 92(3):193-8. PubMed ID: 109259
    [No Abstract]   [Full Text] [Related]  

  • 9. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
    Larochelle P; Haynes B; Maron N; Dugas S
    Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic trial of a new hypotensive agent, Th 2156. Its place in the medical treatment of arterial hypertension].
    Pierron J
    Mars Med; 1966; 103(2):133-7. PubMed ID: 5908585
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical observations on the use of debrisoquine sulphate (Declinas) in the treatment of hypertension.
    Heffernan AG; Carty AT
    Ir J Med Sci; 1970 Jan; 3(1):37-43. PubMed ID: 5444549
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostacyclin biosynthesis in essential hypertension before and during treatment.
    Ritter JM; Brett SE; Woods JD; Benjamin N; Stratton PD; Barrow SE
    J Hum Hypertens; 1996 Jan; 10(1):37-42. PubMed ID: 8642189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Speed and duration of dose titration with the angiotensin converting enzyme inhibitor quinapril: relationship with efficacy in patients with moderate hypertension.
    Weir MR
    J Hum Hypertens; 1994 Sep; 8(9):725-30. PubMed ID: 7807504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory blood pressure monitoring can play an integral role in patient selection, dosage adjustment and efficacy assessment in clinical trials of antihypertensive agents.
    Canter DA; Texter MJ; McLain RW
    J Hypertens Suppl; 1994; 12(7):S33-8. PubMed ID: 7769502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experiences with the new antihypertensive agent Catapresan].
    Messerich J
    Med Klin; 1966 Dec; 61(52):2078-9. PubMed ID: 5999213
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experiences with a new antihypertensive agent].
    Lieb W; Ridders K
    Arzneimittelforschung; 1966 Dec; 16(12):1610-5. PubMed ID: 6014793
    [No Abstract]   [Full Text] [Related]  

  • 17. [DCR 515--a new antihypertensive agent for internal medicine].
    Rummelhardt K
    Hippokrates; 1969 Jan; 40(2):68-71. PubMed ID: 5778774
    [No Abstract]   [Full Text] [Related]  

  • 18. [Longterm treatment with a new antihypertensive agent].
    Wolkerstorfer H
    Wien Med Wochenschr; 1969 Jun; 119(25):502-4. PubMed ID: 5802413
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experiences with a new combination antihypertensive agent (DCR 515)].
    Sterz H; Himmel G; Haas H; Samee HJ
    Wien Klin Wochenschr; 1969 Jan; 81(5):86-90. PubMed ID: 5773905
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contribution to the clinical trial of a new antihypertensive agent].
    Capuano G; Santoro C
    Rass Int Clin Ter; 1969 May; 49(10):615-20. PubMed ID: 5784808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.